•Immunogen design using proprietary algorithms•Modification state-specific antibodies: phospho, methyl, Ac, nitro neoantigen, splice variant•Many species available
•Intact Mass•LCMS•Tandem MS•Protein ID
CoV-2/COVID-19 Information from 21st Century Biochemicals, Inc. The staff at 21st Century Biochemicals hopes that you, your colleagues, and your family and friends are safe. As an essential lab partnering with laboratories around the world to combat the CoV-2/COVID-19 pandemic, we can provide your lab with peptide libraries, protease substrates, and custom peptide and antibody solutions to help you reach your research goals. Variants of Concern/Variants of Interest – Peptide LibrariesVOC: Alpha [UK] B.1.1.7 Beta [SA] B.1.351 Delta [India] B.1.617.2 Gamma [BR] P.1/B.1.1.28 VOI: Epsilon [CA] B.1.429 Iota [NY] B.1.526 Kappa [India] B.1.617.1Recent CoV-2 Publications Citing Our Peptide Libraries and CoV-2 Epitope Synthesis Laboratory of Dr. Dan Barouch Lab, BIDMC: Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans. Alter, G., et al.  (https://www.nature.com/articles/s41586-021-03681-2_reference.pdf) EpiVax, Inc: Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation. Meyers, L., et al.  (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119491/)Click here for more information on COV-2 Variant Peptide librariesFollow Us on Twitter for more information.